{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:49:08Z","timestamp":1791582548843,"version":"4.3.4"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["24KFL089"],"award-info":[{"award-number":["24KFL089"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19401972900"],"award-info":[{"award-number":["19401972900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23Y3192020"],"award-info":[{"award-number":["23Y3192020"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["201940048"],"award-info":[{"award-number":["201940048"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82608627"],"award-info":[{"award-number":["82608627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vph.2026.107705","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:40:38Z","timestamp":1788676838000},"page":"107705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NLRP3 inflammasome\u2013NETosis crosstalk in hypertensive cardiac remodeling: Cellular mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"165","author":[{"given":"Jun","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vph.2026.107705_bb0005","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/CIRCULATIONAHA.118.034028","article-title":"Hypertension in China: time to transition from knowing the problem to implementing the solution","volume":"137","author":"Campbell","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.hfc.2019.06.005","article-title":"The evolution from hypertension to heart failure","volume":"15","author":"Sorrentino","year":"2019","journal-title":"Heart Fail. Clin."},{"issue":"10304","key":"10.1016\/j.vph.2026.107705_bb0015","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 Million participants","volume":"398","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021082","article-title":"The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.vph.2026.107705_bb0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/HYPERTENSIONAHA.124.22973","article-title":"Regarding immune mechanisms driving hypertension in REGARDS","volume":"81","author":"Schiffrin","year":"2024","journal-title":"Hypertension"},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2026.107705_bb0035","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.3109\/07853890.2011.653396","article-title":"Immune mechanisms in angiotensin II-induced target-organ damage","volume":"44","author":"Luft","year":"2012","journal-title":"Ann. Med."},{"issue":"8","key":"10.1016\/j.vph.2026.107705_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"21","key":"10.1016\/j.vph.2026.107705_bb0045","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1080\/15384101.2019.1662678","article-title":"Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-\u03baB signaling in macrophages","volume":"18","author":"An","year":"2019","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.micinf.2018.01.010","article-title":"Leptospira interrogans infection leads to IL-1\u03b2 and IL-18 secretion from a human macrophage cell line through reactive oxygen species and cathepsin B mediated-NLRP3 inflammasome activation","volume":"20","author":"Li","year":"2018","journal-title":"Microbes Infect."},{"key":"10.1016\/j.vph.2026.107705_bb0055","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.2147\/JIR.S493416","article-title":"Elucidating molecule-crosstalk of neutrophil extracellular traps between cardiovascular disease and psoriasis: insights into Mendelian randomization, single-cell RNA analysis, shared targets and the role of resveratrol","volume":"18","author":"Jin","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156453","article-title":"Neutrophil extracellular traps in cardiac hypertrophy: a KLF2 perspective","volume":"132","author":"Riascos-Bernal","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/jch.14942","article-title":"Role of neutrophil extracellular traps in hypertension and their impact on target organs","volume":"27","author":"Yu","year":"2025","journal-title":"J. Clin. Hypertension (Greenwich, Conn.)"},{"issue":"23","key":"10.1016\/j.vph.2026.107705_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232709","article-title":"NLRP3-induced NETosis: a potential therapeutic target for ischemic thrombotic diseases?","volume":"12","author":"Kumar","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.vph.2026.107705_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.683803","article-title":"NLRP3 inflammasome assembly in neutrophils is supported by PAD4 and promotes NETosis under sterile conditions","volume":"12","author":"M\u00fcnzer","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.vph.2026.107705_bb0080","article-title":"The role of extracellular histones in disease progression: a potential therapeutic target for disease modulation","volume":"30","author":"Zhang","year":"2025","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.vph.2026.107705_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.927193","article-title":"Damage associated molecular patterns and neutrophil extracellular traps in acute pancreatitis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.vph.2026.107705_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113783","article-title":"Neutrophil extracellular traps promote the activation of the NLRP3 inflammasome and PBMCs pyroptosis via the ROS-dependent signaling pathway in Kawasaki disease","volume":"145","author":"Jin","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"21","key":"10.1016\/j.vph.2026.107705_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216873","article-title":"The RAAS goodfellas in cardiovascular system","volume":"12","author":"Caputo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vph.2026.107705_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s40885-019-0132-x","article-title":"Blood pressure and heart failure","volume":"26","author":"Oh","year":"2020","journal-title":"Clin. Hypertens."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0110","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2503093","article-title":"Hypertensive heart disease: mechanisms, diagnosis and treatment","volume":"25","author":"Huang","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.vph.2026.107705_bb0115","doi-asserted-by":"crossref","first-page":"H2291","DOI":"10.1152\/ajpheart.00749.2005","article-title":"Costameres, focal adhesions, and cardiomyocyte mechanotransduction","volume":"289","author":"Samarel","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1096\/fj.05-5424rev","article-title":"Cellular mechanotransduction: putting all the pieces together again","volume":"20","author":"Ingber","year":"2006","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S0100-879X2009000100008","article-title":"Focal adhesion kinase signaling in cardiac hypertrophy and failure","volume":"42","author":"Franchini","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"24","key":"10.1016\/j.vph.2026.107705_bb0130","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1101\/gad.1492806","article-title":"Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway","volume":"20","author":"Shiojima","year":"2006","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.vph.2026.107705_bb0135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1006\/jmcc.2002.2011","article-title":"Divergent signaling pathways converge on GATA4 to regulate cardiac hypertrophic gene expression","volume":"34","author":"Liang","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0140","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0092-8674(02)01226-6","article-title":"The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy","volume":"111","author":"Kn\u00f6ll","year":"2002","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.vph.2026.107705_bb0145","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1073\/pnas.260501097","article-title":"Calsarcins, a novel family of sarcomeric calcineurin-binding proteins","volume":"97","author":"Frey","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2026.107705_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9502651","article-title":"Cardiac CaMKII\u03b4 and Wenxin Keli prevents Ang II-induced cardiomyocyte hypertrophy by modulating CnA-NFATc4 and inflammatory signaling pathways in H9c2 cells","volume":"2020","author":"An","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardiores.2004.04.026","article-title":"Role of Ca2+\/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure","volume":"63","author":"Zhang","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.vph.2026.107705_bb0160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What is the role of beta-adrenergic signaling in heart failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.vph.2026.107705_bb0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","article-title":"Endothelins in cardiovascular biology and therapeutics","volume":"16","author":"Dhaun","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0170","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/med.21781","article-title":"NLRP3 inflammasome in cardiovascular diseases: pathophysiological and pharmacological implications","volume":"41","author":"Pellegrini","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0180","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1113\/expphysiol.2012.068338","article-title":"The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1\u03b2","volume":"98","author":"Bracey","year":"2013","journal-title":"Exp. Physiol."},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0185","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"D\u00f6ring","year":"2017","journal-title":"Circ. Res."},{"issue":"6245","key":"10.1016\/j.vph.2026.107705_bb0190","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0195","doi-asserted-by":"crossref","DOI":"10.31083\/RCM38407","article-title":"Programmed cell death in heart failure: mechanisms, impacts, and therapeutic prospects","volume":"26","author":"Wu","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI24569","article-title":"Death begets failure in the heart","volume":"115","author":"Foo","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2026.107705_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720877","article-title":"Novel effects of combination therapy through inhibition of Caspase-1\/Gasdermin D induced-Pyroptosis in lupus nephritis","volume":"12","author":"Cao","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCRESAHA.120.318629","article-title":"GSDMD-mediated cardiomyocyte Pyroptosis promotes myocardial I\/R injury","volume":"129","author":"Shi","year":"2021","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0215","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151268","article-title":"Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0220","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated Ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ. Res."},{"issue":"6586","key":"10.1016\/j.vph.2026.107705_bb0225","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vph.2026.107705_bb0230","article-title":"Mitochondria in pathological cardiac hypertrophy research and therapy","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.vph.2026.107705_bb0235","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"8","key":"10.1016\/j.vph.2026.107705_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/jch.70127","article-title":"Mitophagy in hypertensive cardiac hypertrophy: mechanisms and therapeutic implications","volume":"27","author":"Li","year":"2025","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.vph.2026.107705_bb0245","article-title":"Mitochondrial dysfunction in heart failure and its therapeutic implications","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2026.107705_bb0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1101\/sqb.2011.76.011965","article-title":"Transcriptional control of cardiac fuel metabolism and mitochondrial function","volume":"76","author":"Leone","year":"2011","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"issue":"5","key":"10.1016\/j.vph.2026.107705_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052617","article-title":"The pathogenesis of cardiac fibrosis: a review of recent progress","volume":"23","author":"Maruyama","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010051","article-title":"Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair","volume":"10","author":"Lafuse","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.vph.2026.107705_bb0265","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.7150\/ijbs.28103","article-title":"Cardiac fibrosis: new insights into the pathogenesis","volume":"14","author":"Ma","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0270","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0275","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/CIRCRESAHA.121.318052","article-title":"Hypertension: do inflammation and immunity hold the key to solving this epidemic?","volume":"128","author":"Madhur","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2026.107705_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102515","article-title":"Recent advances in the NEK7-licensed NLRP3 inflammasome activation: mechanisms, role in diseases and related inhibitors","volume":"113","author":"Zhao","year":"2020","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.vph.2026.107705_bb0285","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.vph.2026.107705_bb0290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0295","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00011-023-01831-y","article-title":"The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD","volume":"73","author":"Chu","year":"2024","journal-title":"Inflammation Res."},{"issue":"7371","key":"10.1016\/j.vph.2026.107705_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"issue":"7521","key":"10.1016\/j.vph.2026.107705_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory caspases are innate immune receptors for intracellular LPS","volume":"514","author":"Shi","year":"2014","journal-title":"Nature"},{"issue":"7575","key":"10.1016\/j.vph.2026.107705_bb0310","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.vph.2026.107705_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar6676","article-title":"Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps","volume":"3","author":"Chen","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.vph.2026.107705_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02519","article-title":"Caspase-11 mediates neutrophil chemotaxis and extracellular trap formation during acute gouty arthritis through alteration of Cofilin phosphorylation","volume":"10","author":"Caution","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0325","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05136-z","article-title":"Caspase-11\/GSDMD contributes to the progression of hyperuricemic nephropathy by promoting NETs formation","volume":"81","author":"Wu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.vph.2026.107705_bb0330","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/HYPERTENSIONAHA.122.20004","article-title":"GSDMD (Gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification cascade via mitochondria-STING (stimulator of interferon genes) axis","volume":"79","author":"Han","year":"2022","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0335","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1524-6175.2007.06626.x","article-title":"Mechanisms of cardiac fibrosis in hypertension","volume":"9","author":"D\u00edez","year":"2007","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41420-021-00434-y","article-title":"NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin","volume":"7","author":"Yue","year":"2021","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0345","doi-asserted-by":"crossref","DOI":"10.1080\/10641963.2023.2189138","article-title":"GSDMD-mediated pyroptosis promotes cardiac remodeling in pressure overload","volume":"45","author":"You","year":"2023","journal-title":"Clin. Exp. Hypertens."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7575","key":"10.1016\/j.vph.2026.107705_bb0355","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.vph.2026.107705_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.641585","article-title":"Caspase-1 abrogates the salutary effects of hypertrophic preconditioning in pressure overload hearts via IL-1\u03b2 and IL-18","volume":"8","author":"Dai","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"7717","key":"10.1016\/j.vph.2026.107705_bb0365","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.vph.2026.107705_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112219","article-title":"Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: current knowledge and clinical significance","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.vph.2026.107705_bb0375","article-title":"Nlrp3 deficiency alleviates angiotensin II-induced cardiomyopathy by inhibiting mitochondrial dysfunction","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0380","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0385","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4070\/kcj.2016.0351","article-title":"Association between interleukin-18 level and left ventricular mass index in hypertensive patients","volume":"47","author":"\u00d6zzb\u00ef\u00e7er","year":"2017","journal-title":"Korean Circ. J."},{"issue":"8","key":"10.1016\/j.vph.2026.107705_bb0390","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00011-018-1160-9","article-title":"sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NF\u03baB-NLRP3 activation","volume":"67","author":"Lim","year":"2018","journal-title":"Inflamm. Res."},{"issue":"8029","key":"10.1016\/j.vph.2026.107705_bb0395","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41586-024-07820-3","article-title":"Recognition and control of neutrophil extracellular trap formation by MICL","volume":"633","author":"Malamud","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0400","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00062.2021","article-title":"Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases","volume":"103","author":"Herre","year":"2023","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2026.107705_bb0405","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2024.09.009","article-title":"Neutrophil extracellular traps promote M1 macrophage polarization in gouty inflammation via targeting hexokinase-2","volume":"224","author":"Tan","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0410","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0415","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010231","article-title":"Neutrophil extracellular traps and cardiovascular diseases: an update","volume":"9","author":"Bonaventura","year":"2020","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.vph.2026.107705_bb0425","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148668","article-title":"Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension","volume":"6","author":"Chrysanthopoulou","year":"2021","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0430","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/ATVBAHA.117.309897","article-title":"Novel role of IL (interleukin)-1\u03b2 in neutrophil extracellular trap formation and abdominal aortic aneurysms","volume":"38","author":"Meher","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14030256","article-title":"Endothelial dysfunction: redox imbalance, NLRP3 inflammasome, and inflammatory responses in cardiovascular diseases","volume":"14","author":"Penna","year":"2025","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.vph.2026.107705_bb0440","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.123.323897","article-title":"NETosis drives blood pressure elevation and vascular dysfunction in hypertension","volume":"134","author":"Krishnan","year":"2024","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250265","article-title":"ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo","volume":"16","author":"Hayden","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0450","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","article-title":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation","volume":"184","author":"Wang","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.vph.2026.107705_bb0455","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24437","article-title":"Diverse stimuli engage different neutrophil extracellular trap pathways","volume":"6","author":"Kenny","year":"2017","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0460","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s12026-017-8905-3","article-title":"Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma","volume":"65","author":"Th\u00e5lin","year":"2017","journal-title":"Immunol. Res."},{"issue":"7237","key":"10.1016\/j.vph.2026.107705_bb0465","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0470","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10557-022-07326-y","article-title":"Colchicine inhibits NETs and alleviates cardiac remodeling after acute myocardial infarction","volume":"38","author":"Li","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0475","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cei\/uxae028","article-title":"Neutrophil extracellular traps induce pyroptosis of pulmonary microvascular endothelial cells by activating the NLRP3 inflammasome","volume":"217","author":"Zhao","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vph.2026.107705_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00196","article-title":"Extracellular histone H3 induces pyroptosis during sepsis and may act through NOD2 and VSIG4\/NLRP3 pathways","volume":"10","author":"Shi","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64710-4","article-title":"Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1\u03b2 production, VWF release and NET deposition in the myocardium","volume":"14","author":"Heger","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2026.107705_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108046","article-title":"Selective inhibition of NLRP3 inflammasome reverses pressure overload-induced pathological cardiac remodeling by attenuating hypertrophy, fibrosis, and inflammation","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0495","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147191","article-title":"KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression","volume":"132","author":"Tang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2026.107705_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106055","article-title":"Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction","volume":"78","author":"Du","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.vph.2026.107705_bb0505","article-title":"MCC950, a selective NLRP3 inhibitor, attenuates adverse cardiac remodeling following heart failure through improving the cardiometabolic dysfunction in obese mice","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2026.107705_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.022","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","volume":"74","author":"Gao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.vph.2026.107705_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175364","article-title":"The selective NLRP3 inflammasome inhibitor MCC950 improves isoproterenol-induced cardiac dysfunction by inhibiting cardiomyocyte senescence","volume":"937","author":"Shi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.vph.2026.107705_bb0520","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019177","article-title":"Combined therapy with polyethylene glycol-20k and MCC950 preserves post-resuscitated myocardial function in a rat model of cardiac arrest and cardiopulmonary resuscitation","volume":"10","author":"Liang","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2026.107705_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2024.107397","article-title":"Novel NLRP3 inhibitor INF195: low doses provide effective protection against myocardial ischemia\/reperfusion injury","volume":"156","author":"Gastaldi","year":"2024","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.vph.2026.107705_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2025.107487","article-title":"Macrophage and cardiomyocyte roles in cardioprotection: exploiting the NLRP3 inflammasome inhibitor INF150","volume":"159","author":"Giordano","year":"2025","journal-title":"Vascul. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0535","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107162","article-title":"Inhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis","volume":"26","author":"Hu","year":"2023","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0545","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.20160530","article-title":"Peptidylarginine deiminase 4 promotes age-related organ fibrosis","volume":"214","author":"Martinod","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0550","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jacbts.2016.09.004","article-title":"Myeloperoxidase inhibition improves ventricular function and remodeling after experimental myocardial infarction","volume":"1","author":"Ali","year":"2016","journal-title":"JACC Basic Transl Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00824-4","article-title":"Neutrophil degranulation and myocardial infarction","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"6367","key":"10.1016\/j.vph.2026.107705_bb0560","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aam8897","article-title":"Host DNases prevent vascular occlusion by neutrophil extracellular traps","volume":"358","author":"Jim\u00e9nez-Alc\u00e1zar","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0565","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677040","article-title":"Neutrophil extracellular traps in arterial and venous thrombosis","volume":"45","author":"Laridan","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0570","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00395-026-01177-6","article-title":"Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia\/reperfusion","volume":"121","author":"Rocca","year":"2026","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2026.107705_bb0575","article-title":"The Glp-1 analog Liraglutide protects against angiotensin II and pressure overload-induced cardiac hypertrophy via PI3K\/Akt1 and AMPKa signaling","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2026.107705_bb0580","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S213910","article-title":"Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats","volume":"13","author":"Zheng","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0585","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension","volume":"40","author":"Helmst\u00e4dter","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.vph.2026.107705_bb0590","article-title":"Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1\/NOX4\/ROS pathway in H9c2 cells","volume":"499","author":"C","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.vph.2026.107705_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031177","article-title":"Empagliflozin and liraglutide differentially modulate cardiac metabolism in diabetic cardiomyopathy in rats","volume":"22","author":"Trang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.vph.2026.107705_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14070889","article-title":"Cardioprotection reloaded: reflections on 40 years of research","volume":"14","author":"Pagliaro","year":"2025","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.vph.2026.107705_bb0605","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","article-title":"Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study","volume":"51","author":"Gerdts","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.vph.2026.107705_bb0610","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13050","article-title":"NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice","volume":"19","author":"Mar\u00edn-Aguilar","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.vph.2026.107705_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107001","article-title":"Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease","volume":"145","author":"Alloatti","year":"2022","journal-title":"Vascul. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:53:34Z","timestamp":1791579214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":123,"alternative-id":["S1537189126001254"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107705","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome\u2013NETosis crosstalk in hypertensive cardiac remodeling: Cellular mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107705"}}